MIR146A rs2910164 (G/C) Polymorphism is Associated with Incidence of Preeclampsia in Gestational Diabetes Patients
- 201 Downloads
Preeclampsia and gestational diabetes are common pregnancy disorders that may be interrelated. MIR146A rs2910164 (G/C) is a functional polymorphism that was associated with several diseases. This study aimed to investigate the frequency of rs2910164 polymorphism and its possible correlation with the incidence of preeclampsia in gestational diabetes patients. The study involved 250 pregnant women divided into 80 healthy control subjects, 85 gestational diabetes patients only, and 85 patients of gestational diabetes combined with preeclampsia. Systolic and diastolic blood pressures, urinary proteins, kidney and liver functions, glucose homeostasis parameters, and lipid profile were determined. Genotyping of the polymorphism was conducted by PCR-RFLP. The frequency of the minor C allele of rs2910164 polymorphism was significantly higher among patients of gestational diabetes combined with preeclampsia compared to the control group (p = 0.012) and the gestational diabetes group (p = 0.014). Patients of gestational diabetes and preeclampsia carrying CC genotype showed higher systolic and diastolic blood pressure, and increased urea, creatinine, urine protein, and dyslipidemia compared to the carriers of GG and GC genotypes. In conclusion, the results of the current study suggest that the rare CC genotype of MIR146A rs2910164 (G/C) polymorphism may be related to increased incidence of preeclampsia in gestational diabetes patients.
KeywordsPregnancy Preeclampsia Gestational diabetes MIR146A rs2910164
The authors are thankful to the staff members of the Obstetrics and Gynecology Department in the Suez Canal University Hospital and tha Ismailia General Hospital for their help in the collection of samples.
The work was funded by the authors.
Compliance with Ethical Standards
Conflict of interest
The authors declare no conflict of interests.
All the participants in the study provided written informed consent following a protocol approved by the Research Ethics Committee of Faculty of Pharmacy, Suez Canal University (Code: 201709RH1). The study followed the principles of the Declaration of Helsinki.
- Dziedzic M, Powrózek T, Orłowska E, Koch W, Kukula-Koch W, Gaweł K, Bednarek-Skublewska A, Małecka-Massalska T, Milanowski J, Petkowicz B, Solski J (2017) Relationship between microRNA-146a expression and plasma renalase levels in hemodialyzed patients. PLoS ONE 12(6):e0179218PubMedPubMedCentralCrossRefGoogle Scholar
- Koivusalo SB, Rönö K, Klemetti MM, Roine RP, Lindström J, Erkkola M, Kaaja RJ, Pöyhönen-Alho M, Tiitinen A, Huvinen E, Andersson S, Laivuori H, Valkama A, Meinilä J, Kautiainen H, Eriksson JG, Stach-Lempinen B (2016) Gestational Diabetes mellitus can be prevented by lifestyle intervention: the Finnish Gestational Diabetes Prevention Study (RADIEL): a randomized controlled trial. Diabetes Care 39(1):24–30PubMedCrossRefGoogle Scholar
- Laganà AS, Giordano D, Loddo S, Zoccali G, Vitale SG, Santamaria A, Buemi M, D’Anna R (2017) Decreased Endothelial Progenitor Cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case–control analysis. Arch Gynecol Obstet 295(4):867–872PubMedCrossRefGoogle Scholar
- Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111(5):649–658PubMedPubMedCentralCrossRefGoogle Scholar
- Mehanna ET, Ghattas MH, Mesbah NM, Saleh SM, Abo-Elmatty DM (2015) Association of microRNA-146a rs2910164 gene polymorphism with metabolic syndrome. Folia Biol (Praha) 61(1):43–48Google Scholar